TMDX - TransMedics Group, Inc.

140.07
-7.590   -5.419%

Share volume: 837,710
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$147.66
-7.59
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 25%
Dept financing 21%
Liquidity 65%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.71%
1 Month
3.71%
3 Months
2.54%
6 Months
32.67%
1 Year
114.54%
2 Year
66.71%
Key data
Stock price
$140.07
P/E Ratio 
21.85
DAY RANGE
$137.80 - $147.50
EPS 
$5.60
52 WEEK RANGE
$62.23 - $156.00
52 WEEK CHANGE
$107.63
MARKET CAP 
4.157 B
YIELD 
N/A
SHARES OUTSTANDING 
34.302 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
1.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,257,114
AVERAGE 30 VOLUME 
$863,807
Company detail
CEO: Waleed H. Hassanein
Region: US
Website: transmedics.com
Employees: 210
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.

Recent news